Home › New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug
 

Keywords :   


New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug

2013-10-14 06:06:15| Biotech - Topix.net

A New Zealand biotechnology company, CuroNZ, received funding from the US National Multiply Sclerosis Society worth $540,000 to be used in pre-clinical studies.

Tags: multiple firm drug zealand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Weekly Recap: Rockline Wins WOW Innovation Award, Hospeco Purchases Nuance Solutions & More
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 7A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Eastern North Pacific Tropical Weather Outlook
30.06Atlantic Tropical Weather Outlook
30.06Hurricane Beryl Forecast Discussion Number 7
More »